Iguana Healthcare Management as of Dec. 31, 2017
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 61 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Esperion Therapeutics (ESPR) | 7.1 | $11M | 165k | 65.84 | |
| Celgene Corporation | 5.1 | $7.8M | 75k | 104.36 | |
| Immunomedics | 4.7 | $7.3M | 450k | 16.16 | |
| Biogen Idec (BIIB) | 4.6 | $7.0M | 22k | 318.59 | |
| Humana (HUM) | 3.6 | $5.6M | 23k | 248.09 | |
| CIGNA Corporation | 3.3 | $5.1M | 25k | 203.08 | |
| Aerie Pharmaceuticals | 3.3 | $5.1M | 85k | 59.75 | |
| Global Blood Therapeutics In | 3.2 | $4.9M | 125k | 39.35 | |
| Abbvie (ABBV) | 3.1 | $4.8M | 50k | 96.72 | |
| Merck & Co (MRK) | 2.9 | $4.5M | 80k | 56.28 | |
| Abbott Laboratories (ABT) | 2.8 | $4.3M | 75k | 57.07 | |
| Clovis Oncology | 2.7 | $4.1M | 60k | 68.00 | |
| Anaptysbio Inc Common (ANAB) | 2.6 | $4.0M | 40k | 100.72 | |
| K2m Group Holdings | 2.0 | $3.2M | 175k | 18.00 | |
| Bristol Myers Squibb (BMY) | 2.0 | $3.1M | 50k | 61.28 | |
| Sierra Oncology | 1.9 | $3.0M | 800k | 3.73 | |
| Tesaro | 1.9 | $2.9M | 35k | 82.86 | |
| Karyopharm Therapeutics (KPTI) | 1.9 | $2.9M | 300k | 9.60 | |
| Dermira | 1.8 | $2.8M | 100k | 27.81 | |
| Juno Therapeutics | 1.8 | $2.7M | 60k | 45.72 | |
| Zimmer Holdings (ZBH) | 1.8 | $2.7M | 23k | 120.67 | |
| Sangamo Biosciences (SGMO) | 1.6 | $2.5M | 150k | 16.40 | |
| Intersect Ent | 1.6 | $2.4M | 75k | 32.40 | |
| Danaher Corporation (DHR) | 1.5 | $2.3M | 25k | 92.84 | |
| Ultragenyx Pharmaceutical (RARE) | 1.5 | $2.3M | 50k | 46.38 | |
| Myokardia | 1.4 | $2.1M | 50k | 42.10 | |
| Ionis Pharmaceuticals (IONS) | 1.3 | $2.0M | 40k | 50.30 | |
| Supernus Pharmaceuticals (SUPN) | 1.3 | $2.0M | 50k | 39.86 | |
| Merus N V (MRUS) | 1.3 | $1.9M | 100k | 19.40 | |
| Adma Biologics (ADMA) | 1.2 | $1.9M | 600k | 3.21 | |
| Pfizer (PFE) | 1.2 | $1.8M | 50k | 36.22 | |
| Wave Life Sciences (WVE) | 1.1 | $1.8M | 50k | 35.10 | |
| Puma Biotechnology (PBYI) | 1.1 | $1.7M | 18k | 98.86 | |
| Akcea Therapeutics Inc equities | 1.1 | $1.7M | 100k | 17.36 | |
| Clovis Oncology | 1.1 | $1.7M | 25k | 68.00 | |
| Arena Pharmaceuticals | 1.1 | $1.7M | 50k | 33.98 | |
| Mylan Nv | 1.1 | $1.7M | 40k | 42.30 | |
| Avexis | 1.1 | $1.7M | 15k | 110.67 | |
| Medicines Company | 1.1 | $1.6M | 60k | 27.33 | |
| Allergan | 1.1 | $1.6M | 10k | 163.60 | |
| Ablynx Nv | 1.1 | $1.6M | 65k | 24.88 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $1.6M | 75k | 21.11 | |
| Boston Scientific Corporation (BSX) | 0.8 | $1.2M | 50k | 24.80 | |
| Catalent (CTLT) | 0.8 | $1.2M | 30k | 41.07 | |
| GlaxoSmithKline | 0.7 | $1.1M | 30k | 35.47 | |
| Diplomat Pharmacy | 0.7 | $1.0M | 50k | 20.08 | |
| Regenxbio Inc equity us cm (RGNX) | 0.7 | $998k | 30k | 33.27 | |
| Incyte Corporation (INCY) | 0.6 | $947k | 10k | 94.70 | |
| LHC | 0.6 | $919k | 15k | 61.27 | |
| Viking Therapeutics (VKTX) | 0.6 | $914k | 225k | 4.06 | |
| Corium Intl | 0.6 | $865k | 90k | 9.61 | |
| Voyager Therapeutics (VYGR) | 0.5 | $830k | 50k | 16.60 | |
| Achaogen | 0.5 | $806k | 75k | 10.75 | |
| Marinus Pharmaceuticals | 0.5 | $816k | 100k | 8.16 | |
| Adverum Biotechnologies | 0.5 | $700k | 200k | 3.50 | |
| Oncomed Pharmaceuticals | 0.4 | $615k | 150k | 4.10 | |
| Chemocentryx | 0.4 | $595k | 100k | 5.95 | |
| Scynexis | 0.4 | $580k | 250k | 2.32 | |
| Wright Medical Group Nv | 0.3 | $444k | 20k | 22.20 | |
| Newlink Genetics | 0.3 | $406k | 50k | 8.12 | |
| Transenterix | 0.2 | $241k | 125k | 1.93 |
